# Elevance Health (ELV) — Earnings

ELV · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/elv/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $7.45 |
| EPS estimate | $6.21 |
| EPS surprise | +19.94% |
| Revenue surprise | +2.01% |
| Revenue | $49.8B |
| Revenue estimate | $48.8B |
| Reported | Jul 15, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1156039/000115603926000060/elv-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/958b7688-521c-9205-ec6b-aad50a3101e3.html) |

Elevance Health reported Q2 2026 results on July 15, 2026. Earnings per share were $7.45, ahead of the $6.21 estimate by 19.94%. Revenue was $49.8 billion against a $48.8 billion consensus, a 2.01% beat. Compared with Q2 2025, EPS fell about 16% from $8.84, while revenue rose about 1% from $49.4 billion.

Revenue has grown faster than earnings. Annual revenue rose from about $155.8 billion in 2022 to $197.6 billion in 2025, roughly 27% higher. Annual EPS went from $29.05 in 2022 to $33.11 in 2023, then eased to $32.97 in 2024 and $30.17 in 2025. The first half of 2026 adds up to $20.03, about 4% below the $20.81 a year earlier. Q1 is usually the strongest quarter and Q4 the weakest. Q1 2026 set the high in the table at $12.58, and Q4 2025 the low at $3.33. Over the last 20 quarters, Elevance beat the EPS estimate 17 times. The largest miss was Q3 2024, at 13.33% below.

Elevance reported Q3 between October 17 and October 21 in each of the past five years. That points to mid-to-late October 2026 for the next report. It will show how Q3 compares with $6.03 a year earlier.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 15, 2026 | $6.21 | $7.45 | 19.94% | $48.8B | $49.8B |
| Q1 2026 | Apr 22, 2026 | $11.03 | $12.58 | 14.02% | $48.2B | $49.5B |
| Q4 2025 | Jan 28, 2026 | $3.10 | $3.33 | 7.54% | $49.8B | $49.3B |
| Q3 2025 | Oct 21, 2025 | $4.93 | $6.03 | 22.24% | $49.4B | $50.1B |
| Q2 2025 | Jul 17, 2025 | $8.91 | $8.84 | -0.78% | $48.2B | $49.4B |
| Q1 2025 | Apr 22, 2025 | $11.41 | $11.97 | 4.88% | $46.3B | $48.8B |
| Q4 2024 | Jan 23, 2025 | $4.01 | $3.84 | -4.32% | $45.0B | $45.0B |
| Q3 2024 | Oct 17, 2024 | $9.66 | $8.37 | -13.33% | $43.5B | $44.7B |
| Q2 2024 | Jul 17, 2024 | $10.00 | $10.12 | 1.22% | $43.0B | $43.2B |
| Q1 2024 | Apr 18, 2024 | $10.52 | $10.64 | 1.15% | $42.5B | $42.3B |
| Q4 2023 | Jan 24, 2024 | $5.60 | $5.62 | 0.40% | $42.2B | $42.5B |
| Q3 2023 | Oct 18, 2023 | $8.46 | $8.99 | 6.26% | $42.8B | $42.5B |
| Q2 2023 | Jul 19, 2023 | $8.78 | $9.04 | 2.91% | $41.6B | $43.4B |
| Q1 2023 | Apr 19, 2023 | $9.29 | $9.46 | 1.85% | $40.9B | $41.9B |
| Q4 2022 | Jan 25, 2023 | $5.19 | $5.23 | 0.76% | $39.8B | $39.7B |
| Q3 2022 | Oct 19, 2022 | $7.15 | $7.53 | 5.28% | $39.3B | $39.6B |
| Q2 2022 | Jul 20, 2022 | $7.75 | $8.04 | 3.79% | $37.9B | $38.6B |
| Q1 2022 | Apr 20, 2022 | $7.81 | $8.25 | 5.69% | $37.4B | $37.9B |
| Q4 2021 | Jan 26, 2022 | $5.11 | $5.14 | 0.49% | $36.5B | $36.0B |
| Q3 2021 | Oct 20, 2021 | $6.37 | $6.79 | 6.56% | $35.3B | $35.5B |

## Frequently Asked Questions

### When did Elevance Health (ELV) last report earnings?

Elevance Health last reported on Jul 15, 2026, covering fiscal Q2 2026.

### Did ELV beat earnings estimates?

Yes. Elevance Health reported EPS of $7.45 for Q2 2026 against a $6.21 estimate — a 19.94% beat.

### How much revenue did ELV report last quarter?

Elevance Health reported $49.8B in revenue for Q2 2026, against a consensus estimate of $48.8B.

## Similar Stocks

- [CNC](https://www.lighthorse.io/tickers/cnc) — Centene Corporation Common Stock
- [MOH](https://www.lighthorse.io/tickers/moh) — Molina Healthcare Inc Common Stock
- [UNH](https://www.lighthorse.io/tickers/unh) — UnitedHealth Group Incorporated Common Stock (DE)

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).